Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
143M
-
Number of holders
-
192
-
Total 13F shares, excl. options
-
111M
-
Shares change
-
+15.6M
-
Total reported value, excl. options
-
$3.92B
-
Value change
-
+$557M
-
Put/Call ratio
-
0.3
-
Number of buys
-
122
-
Number of sells
-
-65
-
Price
-
$35.29
Significant Holders of Dyne Therapeutics, Inc. - Common Stock (DYN) as of Q2 2024
221 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock as of Q2 2024.
Dyne Therapeutics, Inc. - Common Stock (DYN) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111M shares
of 143M outstanding shares and own 77.86% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (8.02M shares), FCPM III SERVICES B.V. (7.85M shares), BlackRock Inc. (7.39M shares), RTW INVESTMENTS, LP (6.39M shares), RA CAPITAL MANAGEMENT, L.P. (6.05M shares), FMR LLC (5.32M shares), VANGUARD GROUP INC (4.72M shares), JANUS HENDERSON GROUP PLC (4.62M shares), CITADEL ADVISORS LLC (4.32M shares), and Deep Track Capital, LP (4M shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.